Complement activation plays a key role in the side-effects of rituximab treatment-Reference-Cited by-同舟云学术

Complement activation plays a key role in the side-effects of rituximab treatment

Published:2001-12 Issue:4 Volume:115 Page:807-811
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Van Der Kolk L. E.,Grillo-López A. J.,Baars J. W.,Hack C. E.,Van Oers M. H. J.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.03166.x/fullpdf

Reference26 articles.

1. Pretreatment with divided doses of steroids strongly decreases side effects of OKT3;Bemelman;Kidney International,1994

2. Administration of OKT3 as a two-hour infusion attenuates first-dose side effects;Buysmann;Transplantation,1997

3. PhaseI/II study of thrice weekly rituximab in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): a feasible and active regimen [abstract];Byrd;Blood,1999a

4. Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance;Byrd;Journal of Clinical Oncology,1999b

5. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets;Clynes;Nature Medicine,2000

Cited by 270 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical efficacy of anti-CD20 antibodies in autoimmune diseases;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

2. Therapeutic options for rituximab-resistant patients;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

3. Clinical relevance and therapeutic implications of CD20 expression in Hodgkin's lymphoma;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

4. Pre-Treatment Serum Complement 3 Levels And Rituximab Response In Idiopathic Membranous Nephropathy;Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi;2023-11-20

5. Ocrelizumab‐induced psoriasiform dermatitis: Case reports and review of the literature;JEADV Clinical Practice;2023-09-07